St. Jude Medical (STJ) Becomes Leading Sponsor of Clinical Trial to Study Atrial Fibrillation At Mayo Clinic
Tweet Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced it is the leading sponsor of the Catheter Ablation Versus Anti-arrhythmic Drug Therapy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
